Novo Nordisk Q3 results: Ozempic maker’s profit falls 27%; cuts 9,000 jobs
Novo Nordisk, maker of Ozempic and Wegovy, lowered its 2025 sales outlook for the fourth time, citing slower growth in diabetes and obesity treatments. The ...
Latest Post
Deal approvals: CCI clears Blackstone’s Federal Bank entry; Tata Steel gets nod for BlueScope buyout
The Competition Commission of India has greenlit Blackstone’s acquisition of up to 9.99% stake in Federal Bank via warrants, marking the US private equity giant’s ...
‘Economic golden age’: Donald Trump hails Q3 GDP beat as proof of tariffs push; inflation and jobs data add caution
America’s economy showed robust growth in the third quarter, exceeding expectations. President Donald Trump highlighted this as a success of his policies, including tariffs and ...
Tariff jitters: US consumer confidence slips in December; inflation and jobs worries deepen
US consumer confidence dipped in December to its lowest point since early tariffs, driven by worries over rising prices and trade levies. Households are increasingly ...
US growth rebound: Washington economy expands at 4.3% annual pace in Q3; inflation pressures persist
The US economy surged to a 4.3% annual growth rate in the third quarter, exceeding expectations due to robust consumer spending, exports, and government outlays. ...
Trade friction: China takes India’s solar and IT policies to WTO; consultations initiated
China has initiated a trade dispute against India at the World Trade Organization. The challenge targets India’s policies on solar cells, solar modules, and information ...